Amundi’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $107M | Buy |
362,826
+12,633
| +4% | +$3.73M | 0.04% | 399 |
|
|
2025
Q1 | $108M | Buy |
350,193
+232,988
| +199% | +$71.6M | 0.04% | 384 |
|
|
2024
Q4 | $43M | Buy |
117,205
+51,885
| +79% | +$19M | 0.01% | 587 |
|
|
2024
Q3 | $23.2M | Sell |
65,320
-407,672
| -86% | -$145M | 0.01% | 687 |
|
|
2024
Q2 | $147M | Buy |
472,992
+307,962
| +187% | +$95.8M | 0.06% | 292 |
|
|
2024
Q1 | $39.1M | Sell |
165,030
-24,434
| -13% | -$5.79M | 0.02% | 574 |
|
|
2023
Q4 | $42.5M | Buy |
189,464
+48,150
| +34% | +$10.8M | 0.02% | 566 |
|
|
2023
Q3 | $32.9M | Buy |
141,314
+87,931
| +165% | +$20.5M | 0.02% | 600 |
|
|
2023
Q2 | $11.9M | Buy |
53,383
+28,161
| +112% | +$6.3M | 0.01% | 806 |
|
|
2023
Q1 | $5.88M | Sell |
25,222
-4,471
| -15% | -$1.04M | ﹤0.01% | 962 |
|
|
2022
Q4 | $7.83M | Buy |
29,693
+28,146
| +1,819% | +$7.42M | ﹤0.01% | 904 |
|
|
2022
Q3 | $328K | Buy |
1,547
+18
| +1% | +$3.82K | ﹤0.01% | 1399 |
|
|
2022
Q2 | $363K | Sell |
1,529
-204
| -12% | -$48.4K | ﹤0.01% | 1301 |
|
|
2022
Q1 | $329K | Sell |
1,733
-147
| -8% | -$27.9K | ﹤0.01% | 1329 |
|
|
2021
Q4 | $391K | Hold |
1,880
| – | – | ﹤0.01% | 1415 |
|
|
2021
Q3 | $347K | Hold |
1,880
| – | – | ﹤0.01% | 1374 |
|
|
2021
Q2 | $337K | Buy |
+1,880
| New | +$337K | ﹤0.01% | 1308 |
|